gms | German Medical Science

28. Wissenschaftlicher Kongress der Deutschen Hochdruckliga

24. bis 27.11.2004, Hannover

Hypertension Disease Management in a German Private Health Insurance Health Care Setting

Disease Management Bluthochdruck einer Deutschen Privaten Krankenversicherung

Meeting Abstract (Hypertonie 2004)

  • presenting/speaker K. Lickvers - ArztPartner almeda AG, DKV Deutsche Krankenversicherung (Köln, D)
  • presenting/speaker C. Frye - ArztPartner almeda AG, DKV Deutsche Krankenversicherung (Köln, D)
  • presenting/speaker S. Kottmair - ArztPartner almeda AG, DKV Deutsche Krankenversicherung (Köln, D)
  • presenting/speaker I. Sander - ArztPartner almeda AG, DKV Deutsche Krankenversicherung (Köln, D)
  • presenting/speaker D. Ziegenhagen - ArztPartner almeda AG, DKV Deutsche Krankenversicherung (Köln, D)
  • presenting/speaker B. Derdzinski - ArztPartner almeda AG, DKV Deutsche Krankenversicherung (Köln, D)
  • presenting/speaker M. Middeke - Blutdruckinstitut (München, D)

Hypertonie 2004. 28. Wissenschaftlicher Kongress der Deutschen Hochdruckliga. Hannover, 24.-27.11.2004. Düsseldorf, Köln: German Medical Science; 2005. Doc04hochP97

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/hoch2004/04hoch097.shtml

Published: August 10, 2005

© 2005 Lickvers et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Introduction: In July 2003 a hypertension disease management programm (H-DMP)was started by a german private health insurance (DKV). The H-DMP primarly aims at patient self-management education and compliance support. Firsts results of 100 members are available.

Methods: Participation is voluntary and free of charge. The service elements encompass regular care calls, quality approved patient education material, structured and written feedback for members and physicians (health reports), as well as an individual cardiovascular risk profile for each patient. Treatment targets are in accordance with the evidence based German national hypertension guidelines.

Results: Currently 1,300 members have been enrolled in the H-DMP, while recruitment is still in progress. Mean age is 62, 5+/-9,9 years with 82% male, 33% overweight patients with a mean BMI of 29+/-11,6 kg/m².13% are smokers and 94% are under treatment with antihypertensive drugs.

Results for the first 100 patients after 1 year showed a significant (syst. p<0,0001; diast. p<0,02) blood pressure reduction of 8/2 mmHg and an increase in blood pressure control (<140/90)of patients from 38% to 70% for systolic and from 61% to 75% for diastolic blood pressure.

Conclusion: People who participate in our hypertension-DMP are relatively well treated. Women, overweight patients and smokers as well as insufficient treated hypertensives are obviously not as willing to participate as expected.

The preliminary findings affirm the potential of a comprehensive hypertension-DMP to increase patients compliance and blood pressure control.